skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/22: Research Grant Cycle
Learn more

04/01/23: Fellow Exam Application Deadline
Learn more

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

EDUCATION

The hybrid 2023 AAOA Advanced Course in Allergy & Immunology will take place from Thursday, March 30 - Saturday, April 1, 2023 at the Hythe, Vail, CO (formerly known as the Vail Marriott Mountain Resort). The live–stream content and pre-work will be made available to virtual attendees and live attendees via the Whova app with the pre-work content releasing on March 1, 2023. Learn More and Register Now

RESIDENTS

For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

AAOA Educational Stacks
October 15-December 31, 2022

2023 AAOA Advanced Course in Allergy & Immunology
March 30 - April 1, 2023
The Hythe Vail
Formerly the Vail Marriott Mountain Resort
Learn More and Register

2023 AAOA Basic Course in Allergy & Immunology
June 29 – July 1, 2023
Hyatt Regency Seattle
Learn More and Register

2023 AAOA Annual Meeting
September 28 – September 30, 2023
Embassy Suites by Hilton Nashville Downton

USP 797 Online Module
Learn More and Register

News and Updates

Welcome to the 2017 AAOA Annual Meeting

Offering Winning Strategies for Your Practice By Cecelia Damask, DO, Director of Educational Programs, and Matthew…

Read more

President’s Message: Five Items AAOA Members Need to Know 2017

MACRA  (Medicare Access and CHIP Reauthorization Act) is different from ACA (Affordable Care Act) Most…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Allergic Rhinitis and Nasal Sprays

As indicated in our mission statement, the AAOA is concerned with advancing the treatment of patients with allergic disease.  When the FDA was considering making Nasacort available over-the-counter, the AAOA surveyed our membership about the topic.

The biggest concerns expressed were ensuring patients were getting an accurate diagnosis of their nasal problems, were given good information about available treatment options, and that they were being monitored long-term for potential side effects of medications, such as nasal steroid sprays.

Nasal steroid sprays are a great treatment option for patients with allergic rhinitis. They are generally considered the most effective class of medications available for treating the four major symptoms of allergic rhinitis, particularly nasal obstruction, runny nose, nasal itching, and sneezing. Now that the FDA has approved the over-the-counter availability of Nasacort, we hope that this will make the nasal steroid treatment option more available and affordable for patients with allergic rhinitis. This is what happened after non-sedating antihistamines became available over-the-counter. The AAOA still stresses the importance of patients receiving a good assessment of their nasal problems to make sure the appropriate treatment options are recommended. If nasal steroid sprays appear to be a good option, for some patients it will be more affordable to buy these over-the-counter.  As of now, patients with prescription drug coverage often still get a better price on generic nasal steroid sprays by prescription, compared to purchasing them over-the-counter.  We still recommend the patients have regular examinations of their nose, typically at least once a year, to make sure there are no complications of persistent nasal steroid spray use.

With the approval of Nasacort, more nasal steroid sprays are likely to become available over the counter. The FDA has already approved the Flonase brand for over-the-counter availability. It has been reported online that Flonase will likely become available in stores over-the-counter in early 2015. As multiple nasal steroid sprays become available over-the-counter, it is possible generic brands will also become available, and hopefully competition will result in lower prices.

 

Back To Top